FDA Clears Wearable Device That Monitors Glucose and Ketones Together
The FDA authorized the Libre Duo 10 Day Continuous Dual Glucose-Ketone Monitoring System for people with diabetes aged 2 and older. It is the first wearable to track both glucose and ketones in real time, potentially reducing the need for separate tests. The device can alert users when ketone levels rise, helping to prevent diabetic ketoacidosis.
Related stories
FDA Authorizes Autonomous Blood-Drawing Robot for Outpatient Use · Medical devices
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “FDA Authorizes First Wearable Dual Glucose-Ketone Sensor.” Browse more stories.